StonvexLoading…
StonvexStonvexStonvexCore line items from KN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2024 2024-09-30 | Q2 2024 2024-06-30 | Q1 2024 2024-03-31 | Q3 2023 2023-09-30 |
|---|---|---|---|---|
Revenue | $411.00M | $401.10M | $196.40M | $317.60M |
Operating Income | $36.40M | $17.70M | $5.00M | $32.10M |
Net Income | $-256.30M | $-256.80M | $2.50M | $25.00M |
EPS (Diluted) | $-2.84 | $-2.84 | $0.03 | $0.27 |
Total Assets | $1.17B | $1.18B | $1.48B | $1.18B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $92.60M | $84.00M | $122.10M | $75.10M |
Free Cash Flow OCF − CapEx | $84.70M | $35.60M | $13.90M | $50.50M |
Shares Outstanding | 88.38M | 88.39M | 89.74M | 90.26M |